HLS Therapeutics Inc's market cap is currently ―. The company's EPS TTM is C$-1.15; its P/E ratio is -4.30; and it has a dividend yield of 4.04%. HLS Therapeutics Inc is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is C$-0.22. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 15.86M	$ 16.04M	$ 16.42M	$ 14.76M	$ 15.68M
Gross Profit	$ 13.33M	$ 14.17M	$ 14.64M	$ 13.31M	$ 14.16M
EBIT	$ -2.51M	$ -5.23M	$ -7.39M	$ -3.92M	$ -4.60M
EBITDA	$ 4.53M	$ 2.98M	$ 976.00K	$ 4.40M	-
Net Income Common Stockholders	$ -5.40M	$ -6.90M	$ -9.44M	$ -5.79M	$ -6.43M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 21.95M	$ 21.81M	$ 20.93M	$ 21.21M	$ 20.72M
Total Assets	$ 209.06M	$ 215.23M	$ 226.82M	$ 234.16M	$ 241.65M
Total Debt	$ 6.88M	$ 7.10M	$ 13.01M	$ 95.20M	$ 100.05M
Net Debt	$ -15.08M	$ -14.71M	$ -7.92M	$ 73.98M	$ 79.33M
Total Liabilities	$ 111.36M	$ 113.43M	$ 115.38M	$ 115.26M	$ 116.33M
Stockholders Equity	$ 97.70M	$ 101.80M	$ 111.44M	$ 118.89M	$ 125.32M
Cash Flow	-
Free Cash Flow	$ 3.72M	$ 5.33M	$ 2.53M	$ 4.02M	$ 3.50M
Operating Cash Flow	$ 3.73M	$ 5.37M	$ 2.67M	$ 4.02M	$ 3.52M
Investing Cash Flow	$ -14.00K	$ -40.00K	$ -135.00K	-	$ -20.00K
Financing Cash Flow	$ -3.89M	$ -4.29M	$ -2.95M	$ -3.51M	$ -4.09M

Currency in USD

HLS Therapeutics Inc Earnings and Revenue History

Income Statement >

HLS Therapeutics Inc Debt to Assets

Balance Sheet >

HLS Therapeutics Inc Cash Flow

Cash Flow >

HLS Therapeutics Inc Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing